Zacks Investment Management’s Celgene Corp CELG Stock Holding History

Zacks Investment Management’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-2,171	Closed	-$205K	–	648
2019 Q1	$205K	Buy	+2,171	New	+$190K	﹤0.01%	507
2018 Q1	–	Sell	-2,664	Closed	-$278K	–	671
2017 Q4	$278K	Buy	2,664 +622	+30%	+$70.2K	0.01%	492
2017 Q3	$298K	Buy	2,042 +13	+0.6%	+$1.77K	0.01%	476
2017 Q2	$264K	Sell	2,029 -41	-2%	-$5.02K	0.01%	505
2017 Q1	$258K	Buy	+2,070	New	+$248K	0.01%	522
2016 Q3	–	Sell	-3,829	Closed	-$378K	–	793
2016 Q2	$378K	Sell	3,829 -1,162	-23%	-$120K	0.01%	472
2016 Q1	$500K	Buy	+4,991	New	+$514K	0.02%	449
2015 Q2	–	Sell	-21,060	Closed	-$2.43M	–	795
2015 Q1	$2.43M	Buy	21,060 +5,636	+37%	+$673K	0.08%	171
2014 Q4	$1.73M	Buy	15,424 +9,719	+170%	+$1.03M	0.06%	193
2014 Q3	$541K	Buy	+5,705	New	+$515K	0.02%	383

Other funds holding CELG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Zacks Investment Management's CELG Position: Q2 2019 in Review

Zacks Investment Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,171 shares — an estimated $205K sold.

Zacks Investment Management first reported a position in CELG in Q3 2014 and held it in 10 quarters. The position peaked at $2.43M in Q1 2015. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

Zacks Investment Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
Zacks Investment Management sold 2,171 Celgene Corp shares in Q2 2019, an estimated $205K.
Zacks Investment Management first reported a position in Celgene Corp in Q3 2014 and held it in 10 quarters.
Zacks Investment Management's Celgene Corp position peaked at $2.43M in Q1 2015.
1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Zacks Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.